Clinical Trial Update: A Study Comparing LBAL to Humira® in Subjects With Active Rheumatoid Arthritis Despite Methotrexate Therapy [Phase 3]

View source ↗

Summary

Phase 3 trial comparing LBAL to Humira in patients with active rheumatoid arthritis despite methotrexate therapy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Humira (adalimumab)
• LBAL (LBAL)

Snippet

Sponsor: LG Life Sciences | Conditions: Arthritis, Rheumatoid | Phase 3 | Status: COMPLETED